Cogent Communications Holdings, Inc.（NASDAQ:CCOI）副总裁兼首席财务官Thaddeus Weed近期出售了4,900股公司普通股。每股售价为$72.0632，交易总额达$353,109。根据 InvestingPro 数据显示，该公司股票在过去一周下跌了10%。此次交易后，Weed直接持有103,000股。这项交易已向美国证券交易委员会备案，为投资者提 ...

根据最新的SEC文件显示，Cogent Communications Holdings, Inc.（NASDAQ:CCOI）的董事Sheryl ...

Cogent Communications Holdings, Inc. ( NASDAQ:CCOI ) has announced that it will be increasing its dividend from ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

COGENT COMMUNICATIONS HLDGS ($CCOI) posted quarterly earnings results on Thursday, February 27th. The company reported earnings of -$0.91 per share, beating estimates ...

Needham & Company LLC reaffirmed their hold rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research report report published on Wednesday,Benzinga reports. A number of other ...

(RTTNews) - Cogent Biosciences ... Currently, COGT is trading at $6.89 up by 2.61 percent on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and ...

Analysts at Zacks Research upped their FY2024 earnings per share (EPS) estimates for shares of Cogent Communications in a research note issued on Monday, February 24th. Zacks Research analyst R.

Total Symptom Score (TSS) at 48 weeks, including 88% of patients achieving at least a 50% reduction in TSSTop-line ...

and BOULDER, Colo., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases ...

and BOULDER, Colo., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases ...